iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionGts Securities Llc
Latest Disclosed Ownership3,671 shares
Latest Disclosed Value $ 619,848
Gts Securities Llc ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Gts Securities Llc filed a 13F-HR form disclosing ownership of 3,671 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $619,848 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 26,871 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -86.34% during the quarter. The current value of the position is $481,085 USD.

Gts Securities Llc has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,671 -23,200 -86.34 620 -86.35 0.0219
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 26,871 -12,328 -31.45 4,535 -19.86 0.1547
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 39,199 39,199 5,659 0.2173
2025-08-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -72,376 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 72,376 25,656 54.91 9,257 49.89 0.4007
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 46,720 -2,668 -5.40 6,175 -14.12 0.3008
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 49,388 -5,381 -9.82 7,190 -4.34 0.0156
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 54,769 5,717 11.65 7,517 11.63 0.0160
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 49,052 -1,133 -2.26 6,734 -1.20 0.0124
2024-02-15 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 50,185 -267 -0.53 6,816 10.44 0.0116
2023-11-15 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 50,452 -3,101 -5.79 6,171 -9.25 0.0111
2023-08-16 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 53,553 53,553 6,801 0.2149
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH Call 23,600 30.39 3,436 38.33 n/a n/a n/a
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH Call 18,100 -37.59 2,484 -37.57 n/a n/a n/a
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH Call 29,000 -12.39 3,979 -11.50 n/a n/a n/a
2024-02-15 2023-12-31 13F ISHARES TR ISHARES BIOTECH Call 33,100 133.10 4,497 158.99 n/a n/a n/a
2023-11-15 2023-09-30 13F ISHARES TR ISHARES BIOTECH Call 14,200 1,737 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-18 2024-12-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH Put 71,600 -17.32 10,425 -12.30 n/a n/a n/a
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH Put 86,600 8.11 11,887 8.14 n/a n/a n/a
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH Put 80,100 -72.36 10,991 -72.08 n/a n/a n/a
2024-02-15 2023-12-31 13F ISHARES TR ISHARES BIOTECH Put 289,800 195.71 39,369 228.51 n/a n/a n/a
2023-11-15 2023-09-30 13F ISHARES TR ISHARES BIOTECH Put 98,000 11,984 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.